QLTY GMO US Quality ETF

Expense Ratio
0.5%
Dividend
0.80%
Previous close
$36.58
Est. 12 months change
+23.75%
Projected Price
$45.27

Profitability Metrics

Return on Equity (ROE)
41.89%
Return on Assets (ROA)
12.01%
Return on Invested Capital (ROIC)
30.35%
Weighted Average Cost of Capital (WACC)
8.98%
ROIC - WACC
21.37%
Updated : 2026-04-03 19:40 ET

Valuation Metrics

P/E Ratio
25.51
Forward P/E
20.80
PEG Ratio
1.95
Debt Current Ratio
1.65

Growth & Cash Flow

Gross Margin
57.61%
Operating Margin
29.58%
FCF Margin
21.93%
TTM Revenue Growth
13.67%
Projected 12M EPS Growth
22.66%

Price Change

Price % from 50 SMA
-3.71%
Price % from 200 SMA
-0.54%
6 Months
-0.49%
1 Year
16.65%
2 Years
24.59%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MSFT5.44%
GOOGL5.42%
JNJ5.03%
LRCX4.98%
META4.80%
AAPL4.58%
AVGO4.01%
KLAC3.79%
CRM3.59%
TXN3.43%

ETF Analysis

Fund Overview

GMO US Quality ETF (QLTY) currently reports 38 stock positions (subject to change), placing it in the balanced in breadth range by holdings breadth. The top line-up is MSFT (5.44%), GOOGL (5.42%), JNJ (5.03%), with MSFT as the largest single weight at 5.44%. Together, the top three holdings account for 15.89%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 30.35%, WACC is 8.98%, and the economic spread is 21.37%. On balance, the economic spread is positive and meaningful, suggesting the underlying holdings are building rather than eroding intrinsic value. Supporting metrics show ROE at 41.89% and ROA at 12.01%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Assessed on a multiple basis, trailing P/E of 25.51, forward P/E of 20.80, PEG of 1.95. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. Growth-adjusted, the multiple is in an acceptable range — the portfolio is neither pricing in perfection nor offering a meaningful valuation discount. The portfolio carries an aggregate current ratio of 1.65, consistent with adequate near-term liquidity management. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 57.61%, operating margin at 29.58%, and free cash flow margin at 21.93%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are constructive here, reflecting holdings that generate cash reliably after reinvestment requirements. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.

Growth & Forward Outlook

Where growth and expectations intersect, the estimated 12-month price change of 23.99%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 13.67% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 22.7% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Putting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.